About the Product

Description


Bringcetam 75 Tablet containing Brivaracetam is used for the management of seizures and epilepsy under medical supervision. It helps support stable neurological activity and seizure control.

Brivaracetam works by binding to synaptic vesicle proteins in the brain, thereby helping regulate abnormal electrical activity associated with seizures.

The tablet is widely prescribed in neurology practice for epilepsy and seizure disorder management, leading to consistent prescription demand.

With increasing awareness of neurological healthcare and growing demand for advanced anti-epileptic therapies, this product offers strong business potential for authorized distributors and healthcare suppliers. Its established therapeutic role, broad clinical relevance, and steady prescription demand make it a valuable product for growth in the neuro care segment.

Some patients may experience drowsiness, dizziness, fatigue, nausea, irritability, or headache. Rarely, mood changes, depression, suicidal thoughts, or severe allergic reactions may occur and require immediate medical attention.

Bringcetam 75 Tablet is indicated for partial-onset seizures and epilepsy in adults and adolescents as prescribed by a healthcare professional. It helps reduce seizure frequency, improve neurological stability, and support better quality of life.

This medicine should be used strictly under medical supervision. Do not stop the medicine abruptly, as it may increase the risk of seizures. Avoid alcohol and activities requiring mental alertness until the medicine’s effects are known.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Bringcetam 75 Tablet in the PCD pharma franchise market?

Bringcetam 75 Tablet, containing Brivaracetam 75mg, has strong demand in the neurology and anti-epileptic segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on seizure disorder and CNS care portfolios.

Why should medical distributors include Bringcetam 75 Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for antiepileptic therapy used in partial-onset seizures and epilepsy management. Brivaracetam offers improved seizure control with better CNS selectivity, strengthening a specialized neurology product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Bringcetam 75 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Bringcetam 75 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Bringcetam 75 Tablet distribution?

Wholesalers and medical agencies benefit from steady neurology prescription demand, long-term chronic therapy usage, hospital and neurologist prescriptions, reliable supply chain support, and good margins when partnering for Bringcetam 75 Tablet distribution.

How can I become a distributor or franchise partner for Bringcetam 75 Tablet?

Medical distributors, stockists, and wholesalers interested in Bringcetam 75 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.